Biozona Weekly: HTG Molecular offering; TGen research; Phoenix Forward

May 8, 2015

By Matt Ellsworth

Tucson’s HTG Molecular goes public, shares drop 23 cents
5/6/15 | Arizona Daily Star | David Wichner

Tucson biotech company HTG Molecular Diagnostics Inc., with its patented chemistry technology HTG Edge, had an initial public offering priced at $14 per share, closing at $13.77 in its first day of trading on the Nasdaq’s Global Market. Read also: Tucson biotech firm HTG about to go public

Arizona man receives double lung transplant at St Joseph’s Hospital
5/5/15 | Fox 10 News | Courtney Griffin

A 72-year-old man received a double lung transplant after being on the waiting list for only 20 days at St. Joseph’s Hospital and Medical Center.

TGen partnership study advances research on often-fatal brain tumor
5/4/15 | KJZZ | Andrew Bernier

Phoenix researchers are studying one of the most deadly forms of brain cancer, and tests are narrowing down possible treatments with the hope of combatting its growth with FDA-approved drugs.

Eight companies graduate from Phoenix exporting boot camp
5/4/15 | Phoenix Business Journal | Eric Jay Toll

Bioscience companies were among those graduating from the Arizona Commerce Authority’s third ExporTech, co-sponsored by the city of Phoenix, that stresses the importance of exports to the state economy.

UA student venture startups: We have a winner
5/1/15 | Arizona Daily Star | Staff Report

More than 80 University of Arizona McGuire Entrepreneurship Program students pitched venture ideas in rapid-fire, three-minute presentations to compete for $45,000 in cash and prizes.

Tucson Medical Center partners with Mayo Clinic
5/1/15 | Tucson News Now | Barbara Grijalva

Tucson Medical Center is teaming up with Mayo Clinic to allow doctors affiliated with the hospital to consult electronically with Mayo medical teams–a relationship Mayo Clinic has with only about 30 hospitals in the world.

Arizona partnership opens door for food-borne illness vaccine
4/30/15 | KJZZ | Andrew Bernier

A vaccine designed to combat campylobacter, a common bacterial infection in chickens passed onto humans, is moving from research to development because of a local partnership between the University of Arizona, Arizona State University and Tucson-based biotech company Anivax.

What’s behind the lack of women in STEM careers–and how to change it
4/30/15 | Phoenix Business Journal | Hayley Ringle

Mitzi Montoya, vice president and dean of Arizona State University’s Entrepreneurship and Innovation Group, addressed the Girls in Tech conference in Phoenix about the low number of women working in STEM fields.

$1.5 million Phoenix Forward initiative will help businesses create key jobs
4/29/15 | Arizona Republic | Ronald J. Hansen & Ryan Randazzo

The $1.5 million Phoenix Forward initiative led by the Greater Phoenix Chamber of Commerce will focus on bioscience, health care, advanced business and financial services, and transportation and logistics, areas officials see as ripe for faster expansion. Read also: Why the Phoenix Chamber is moving forward with biz expansion plan